SOLV · NYSE · CIK 0001964738
Solventum Corp
Solventum Corp’s most recent SEC filing in our snapshot is a Form 4 filed on Sep 3, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $8.3B and net income of $1.6B, according to its XBRL data on EDGAR. Its EDGAR record lists 57 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Solventum Corp
- Ticker
- SOLV
- SEC Central Index Key (CIK)
- 0001964738
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus (code 3841)
- Business address
- EAGAN, MN
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #710 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Solventum Corp’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|
| Revenue | $8.1B | $8.2B | $8.3B | $8.3B |
| Net income | $1.3B | $1.3B | $479.0M | $1.6B |
| Diluted EPS | $7.78 | $7.79 | $2.76 | $8.88 |
| Total assets | — | $13.9B | $14.5B | $14.3B |
| Cash and equivalents | $61.0M | $194.0M | $762.0M | $878.0M |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Feb 27, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 5, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Results of operations· period Aug 5, 2026 | Document · Index |
| Mar 27, 2026 | DEF 14A | Definitive proxy statement· period Dec 31, 2025 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Solventum Corp, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Sep 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026 | Document · Index |
| Aug 18, 2026 | 3 | Initial statement of beneficial ownership· period Aug 10, 2026 | Document · Index |
| Aug 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 17, 2026 | Document · Index |
| Aug 5, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Results of operations· period Aug 5, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Regulation FD disclosure; Other events· period Aug 5, 2026 | Document · Index |
| Jul 20, 2026 | 8-K | Director or officer change· period Jul 16, 2026 | Document · Index |
| Jun 5, 2026 | 8-K | Other events· period Jun 2, 2026 | Document · Index |
| May 29, 2026 | SD | Specialized disclosure report (conflict minerals) | Document · Index |
| May 27, 2026 | 8-K | Director or officer change· period May 21, 2026 | Document · Index |
| May 20, 2026 | 8-K | Shareholder vote results· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 18, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 15, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 13, 2026 | Document · Index |
| May 5, 2026 | 10-Q | Quarterly report· period Mar 31, 2026 | Document · Index |
| May 5, 2026 | 8-K | Results of operations· period May 5, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
| May 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 30, 2026 | Document · Index |
Insider filing activity
57 Form 4 filings appear in Solventum Corp’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Surgical & Medical Instruments & Apparatus
- SYK STRYKER CORP
- MMM 3M CO
- BSX BOSTON SCIENTIFIC CORP
- BDX BECTON DICKINSON & CO
- MDLN Medline Inc.
- RMD RESMED INC
- DXCM DEXCOM INC
- WST WEST PHARMACEUTICAL SERVICES INC
All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Minnesota
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001964738 and XBRL company facts. Solventum Corp on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement